首页> 外文期刊>Medical science monitor: international medical journal of experimental and clinical research >The application of Levulan?-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma
【24h】

The application of Levulan?-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma

机译:咪喹莫特基于Levulan?的光动力疗法在复发性基底细胞癌治疗中的应用

获取原文
获取原文并翻译 | 示例

摘要

Background: Common skin tumors like basal- and squamous-cell carcinoma present a serious problem in modern medicine. Exposure to ultraviolet solar radiation is the main cause of these lesions. Since application of Aldara? and PDT separately is well documented, we decided to use both methods together. Material/Methods: The aim of our study was to evaluate the effectiveness of local photodynamic therapy supplemented with topical application of Aldara? in basal-cell carcinoma.Thirty-four patients ages 50 to 68 years were enrolled to the trial and underwent PDT treatment. Each case of BCC was histopathologically confrmed. Ten patients were subjected to local Levulan?-PDT and placebo (Eucerin as vehicle cream), and 24 patients were subjected to Levulan?-PDT and im-iquimod. Photodynamic diagnosis (PDD) was used to detect and visualize suspicious foci (including cancer lesions). Results: In the group of patients who were treated using Levulan?-PDT and placebo, 6 patients (60) were totally cured and 4 lesions (40) significantly decreased in size. In the group of patients treated with Levulan?-PDT and imiquimod, 18 lesions totally disappeared (75), 6 lesions significantly diminished, and in 1 patient small foci of previously excised BCC developed again in scar tissue 10 month after the frst control examination. Conclusions: Cure was achieved without any scarring and with very good cosmetic effects. Although this is the preliminary report, the presented modifcation of PDT seems to be reasonable and promising in treating basal-cell carcinoma.
机译:背景:常见的皮肤肿瘤,如基底细胞癌和鳞状细胞癌,在现代医学中是一个严重的问题。暴露于紫外线太阳辐射是这些病变的主要原因。自从应用Aldara?和 PDT 单独有据可查,我们决定同时使用这两种方法。材料/方法:我们研究的目的是评估局部光动力疗法辅以 Aldara?在基底细胞癌中。34 名年龄在 50 至 68 岁之间的患者被纳入试验并接受了 PDT 治疗。每例基底细胞癌都经过组织病理学检查。10 例患者接受局部 Levulan?-PDT 和安慰剂(Eucerin 作为载体乳膏),24 例患者接受 Levulan?-PDT 和 im-iquimod。光动力诊断(PDD)用于检测和可视化可疑病灶(包括癌症病变)。结果:在接受Levulan?-PDT和安慰剂治疗的患者中,6例患者(60%)完全治愈,4例(40%)病灶面积明显缩小。在接受Levulan?-PDT和咪喹莫特治疗的患者中,18例病灶完全消失(75%),6例病灶明显缩小,1例患者在第一次对照检查后10个月再次在瘢痕组织中出现先前切除的BCC小病灶。结论:治愈时无瘢痕,美容效果非常好。虽然这是初步报告,但所提出的 PDT 修改似乎在治疗基底细胞癌方面是合理且有希望的。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号